XBI
SPDR S&P Biotech ETF

Up$87.01
+$2.07
(+2.44%)
As of 10:51:10 AM EDT | 10/16/18  |  Market Open

XBI Trading Data

Open

$85.8

Low Price

$85.47

High Price

$87.01

Previous Last Price

$84.94

Bid Size

$87.01 X 200

Ask Size

$87.02 X 2300

XBI Portfolio Data

AUM

$5,050,938,000

Shares

58,650

PE Ratio

22.01

Price / Book Ratio

5.55

Expense Ratio

0.35

Net Asset Value

$86.12

Volume

Volume

1,915,694

Avg. Volume (YDT)

4,482,727

Dollar Volume

$150,340,538

Weekly Avg. Volume

4,990,090

Monthly Avg. Volume

4,290,857

Quarterly Avg. Volume

3,919,819

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

ACADIA Pharmaceuticals Inc. (ACAD)
2.18%
TESARO Inc. (TSRO)
1.62%
Viking Therapeutics Inc. (VKTX)
1.56%
Amicus Therapeutics Inc. (FOLD)
1.47%
Alexion Pharmaceuticals Inc. (ALXN)
1.44%
Vertex Pharmaceuticals Incorporated (VRTX)
1.41%
Alkermes Plc (ALKS)
1.41%
Gilead Sciences Inc. (GILD)
1.4%
BioMarin Pharmaceutical Inc. (BMRN)
1.4%
Loxo Oncology Inc (LOXO)
1.4%

Total XBI Holdings

Total Holdings: 128

ACADIA Pharmaceuticals Inc. (ACAD)
2.18%
TESARO Inc. (TSRO)
1.62%
Viking Therapeutics Inc. (VKTX)
1.56%
Amicus Therapeutics Inc. (FOLD)
1.47%
Alexion Pharmaceuticals Inc. (ALXN)
1.44%
Vertex Pharmaceuticals Incorporated (VRTX)
1.41%
Alkermes Plc (ALKS)
1.41%
Gilead Sciences Inc. (GILD)
1.4%
BioMarin Pharmaceutical Inc. (BMRN)
1.4%
Loxo Oncology Inc (LOXO)
1.4%
United Therapeutics Corporation (UTHR)
1.39%
Array BioPharma Inc. (ARRY)
1.38%
Amgen Inc. (AMGN)
1.37%
Regeneron Pharmaceuticals Inc. (REGN)
1.37%
Ionis Pharmaceuticals Inc. (IONS)
1.37%
Biogen Inc. (BIIB)
1.37%
Esperion Therapeutics Inc. (ESPR)
1.35%
Immunomedics Inc. (IMMU)
1.34%
Exelixis Inc. (EXEL)
1.34%
Celgene Corporation (CELG)
1.33%
AbbVie Inc. (ABBV)
1.32%
Sangamo Therapeutics Inc. (SGMO)
1.32%
Neurocrine Biosciences Inc. (NBIX)
1.31%
Seattle Genetics Inc. (SGEN)
1.3%
Incyte Corporation (INCY)
1.28%
Myriad Genetics Inc. (MYGN)
1.28%
Puma Biotechnology Inc. (PBYI)
1.27%
Agios Pharmaceuticals Inc. (AGIO)
1.25%
Exact Sciences Corporation (EXAS)
1.23%
AnaptysBio Inc. (ANAB)
1.21%
bluebird bio Inc. (BLUE)
1.21%
Intercept Pharmaceuticals Inc. (ICPT)
1.2%
Sarepta Therapeutics Inc. (SRPT)
1.19%
OPKO Health Inc. (OPK)
1.19%
Heron Therapeutics Inc (HRTX)
1.18%
Blueprint Medicines Corp. (BPMC)
1.18%
Madrigal Pharmaceuticals Inc. (MDGL)
1.18%
Alnylam Pharmaceuticals Inc (ALNY)
1.18%
SAGE Therapeutics Inc. (SAGE)
1.18%
Clovis Oncology Inc. (CLVS)
1.17%
Arena Pharmaceuticals Inc. (ARNA)
1.17%
Editas Medicine Inc. (EDIT)
1.16%
PTC Therapeutics Inc. (PTCT)
1.15%
FibroGen Inc. (FGEN)
1.15%
Enanta Pharmaceuticals Inc. (ENTA)
1.15%
Radius Health Inc (RDUS)
1.15%
Portola Pharmaceuticals Inc. (PTLA)
1.14%
Spark Therapeutics Inc. (ONCE)
1.14%
Ligand Pharmaceuticals Incorporated (LGND)
1.11%
Global Blood Therapeutics Inc (GBT)
1.1%
REGENXBIO Inc. (RGNX)
1.04%
Ultragenyx Pharmaceutical Inc. (RARE)
1.04%
Atara Biotherapeutics Inc (ATRA)
1%
Spectrum Pharmaceuticals Inc. (SPPI)
0.99%
ImmunoGen Inc. (IMGN)
0.95%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.92%
Mirati Therapeutics Inc. (MRTX)
0.91%
Genomic Health Inc. (GHDX)
0.91%
Arrowhead Pharmaceuticals Inc. (ARWR)
0.88%
Eagle Pharmaceuticals Inc. (EGRX)
0.82%
Intrexon Corporation (XON)
0.82%
Acceleron Pharma Inc (XLRN)
0.8%
Emergent BioSolutions Inc. (EBS)
0.75%
Insmed Incorporated (INSM)
0.74%
Intellia Therapeutics Inc. (NTLA)
0.71%
MiMedx Group Inc. (MDXG)
0.69%
Dynavax Technologies Corporation (DVAX)
0.68%
AMAG Pharmaceuticals Inc. (AMAG)
0.67%
Halozyme Therapeutics Inc. (HALO)
0.66%
Repligen Corporation (RGEN)
0.65%
Cara Therapeutics Inc (CARA)
0.63%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
0.63%
Vericel Corporation (VCEL)
0.6%
Iovance Biotherapeutics Inc (IOVA)
0.59%
Acorda Therapeutics Inc. (ACOR)
0.56%
Verastem Inc. (VSTM)
0.54%
Adamas Pharmaceuticals Inc. (ADMS)
0.54%
Alder Biopharmaceuticals Inc. (ALDR)
0.54%
Aimmune Therapeutics Inc (AIMT)
0.53%
Natera Inc. (NTRA)
0.52%
Progenics Pharmaceuticals Inc. (PGNX)
0.52%
Flexion Therapeutics Inc. (FLXN)
0.51%
Vanda Pharmaceuticals Inc. (VNDA)
0.47%
La Jolla Pharmaceutical Company (LJPC)
0.45%
Novavax Inc. (NVAX)
0.4%
CytomX Therapeutics Inc. (CTMX)
0.4%
Sorrento Therapeutics Inc. (SRNE)
0.4%
Audentes Therapeutics Inc. (BOLD)
0.4%
G1 Therapeutics Inc. (GTHX)
0.38%
Coherus BioSciences Inc. (CHRS)
0.35%
Retrophin Inc. (RTRX)
0.35%
Abeona Therapeutics Inc. (ABEO)
0.35%
TG Therapeutics Inc. (TGTX)
0.34%
GlycoMimetics Inc. (GLYC)
0.33%
ArQule Inc. (ARQL)
0.32%
Xencor Inc. (XNCR)
0.32%
Invitae Corp. (NVTA)
0.31%
CareDx Inc. (CDNA)
0.31%
Voyager Therapeutics Inc. (VYGR)
0.31%
Prothena Corp. Plc (PRTA)
0.3%
Momenta Pharmaceuticals Inc. (MNTA)
0.3%
Fate Therapeutics Inc. (FATE)
0.3%
Lexicon Pharmaceuticals Inc. (LXRX)
0.27%
Rigel Pharmaceuticals Inc. (RIGL)
0.27%
Karyopharm Therapeutics Inc. (KPTI)
0.26%
Deciphera Pharmaceuticals Inc. (DCPH)
0.25%
Akebia Therapeutics Inc. (AKBA)
0.24%
Rhythm Pharmaceuticals Inc. (RYTM)
0.24%
Epizyme Inc. (EPZM)
0.24%
Apellis Pharmaceuticals Inc. (APLS)
0.23%
Five Prime Therapeutics Inc. (FPRX)
0.23%
Kura Oncology Inc. (KURA)
0.23%
Athenex Inc. (ATNX)
0.22%
Keryx Biopharmaceuticals Inc. (KERX)
0.22%
BioCryst Pharmaceuticals Inc. (BCRX)
0.22%
Geron Corporation (GERN)
0.2%
Synergy Pharmaceuticals Inc. (SGYP)
0.19%
MacroGenics Inc. (MGNX)
0.19%
PDL BioPharma Inc. (PDLI)
0.18%
Inovio Pharmaceuticals Inc. (INO)
0.16%
ZIOPHARM Oncology Inc. (ZIOP)
0.16%
Achillion Pharmaceuticals Inc. (ACHN)
0.14%
Stemline Therapeutics Inc. (STML)
0.12%
Cytokinetics Incorporated (CYTK)
0.09%
STATE STREET INSTL US GOVERNME OPEN-END (Unassigned)
0.05%
SPDR S & P Biotech ETF (XBI)
0%
Achaogen Inc. (AKAO)
0%
U.S. Dollar
0%

XBI Technicals

Alpha

-6.46

Beta

1.5

Leverage

Long

Standard Deviation

5.7

XBI Dividends

Dividend Date

2018-09-21

Latest Dividend

0.073

Annual Dividend

0.22

Annual Dividend Rate

0.22

Annual Dividend Yield

0.26

XBI Performance

YTD Return

2.62%

1 Year Return

0.2%

3 Year Return

29.34%

5 Year Return

104.64%

10 Year Return

376.39%

XBI Related Articles

Catalysts Abound for Biotech ETFs

Catalysts Abound for Biotech ETFs

Biotechnology stocks and biotech ETFs tumbled in the back half of March and to start April. For example, the SPDR S&P Biotech ETF (NYSEArca: XBI) came into Monday with a…

Alkermes FDA Refusal: Biotech ETFs Dragged Down

Alkermes FDA Refusal: Biotech ETFs Dragged Down

Biotechnology stocks and biotech ETFs were among the worst performing areas of the markets Monday as Alkermes (NasdaqGS: ALKS) shares plunged after the U.S. food and Drug Administration refused to…

Healthcare Dip Could be a Buying Opportunity

Healthcare Dip Could be a Buying Opportunity

The Health Care Select Sector SPDR (NYSEArca: XLV), the largest exchange traded fund dedicated to the S&P 500’s third-largest sector weight, tumbled last week, but some market observers believe the…

Biotech ETFs Pop on Celgene, Juno Deal

Biotech ETFs Pop on Celgene, Juno Deal

Biotechnology sector-related ETFs surged Monday after Celgene (NasdaqGS: CELG) said it will acquire Juno Therapeutics (NasdaqGS: JUNO) to expand its cancer treatment profile. Among the best performing biotech-related ETFs, the…